An investment in an equity portfolio should be made with an understanding of the risks associated with an investment in common stocks including the risk that the financial condition of the issuers of the equities or the general condition of the stock market may worsen.
A portfolio which is concentrated in an individual sector is subject to additional risks, including limited diversification.
The companies engaged in the health care sector are subject to fierce competition, high research and development costs, governmental regulations, loss of patent protection, and changing consumer spending trends. In addition, passage of the Health Care and Education Affordability Reconciliation Act of 2010 has had and will continue to have a significant impact on the health
The value of the securities held by the trust may be subject to steep declines or increased volatility due to changes in performance or perception of the issuers.
This product information does not constitute an offer to sell, or a solicitation of an offer to buy securities in any state to any person to whom it is not lawful to make such an offer. Sales of any of these securities must include prospectus delivery and the services of a retail broker/dealer duly licensed in the appropriate states.
Not FDIC Insured, Not Bank Guaranteed and May Lose Value.
The "Dow Jones Industrial Average" is a product of S&P Dow Jones Indices LLC ("SPDJI"),
and has been licensed for use by First Trust Advisors L.P. Standard & Poor's® and S&P® are
registered trademarks of Standard & Poor's Financial Services LLC ("S&P"); DJIA®, The
Dow®, Dow Jones®, and Dow Jones Industrial Average are trademarks of Dow Jones
Trademark Holdings LLC ("Dow Jones"); and these trademarks have been licensed for use
by SPDJI and sublicensed for certain purposes by First Trust Advisors L.P. The Dow® Target
Dividend, based on a strategy based on the Dow Jones Industrial Average, is not
sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, their respective
affiliates, and none of such parties make any representation regarding the advisability of
investing in such products.